Tech Company Financing Transactions
VentiRx Pharmaceuticals Funding Round
VentiRx Pharmaceuticals closed a $19.4 million financing round on 9/23/2014. Backers included private investors.
Transaction Overview
Company Name
Announced On
9/23/2014
Transaction Type
Venture Equity
Amount
$19,352,414
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1191 Second Ave. 1105
Seattle, WA 98101
USA
Seattle, WA 98101
USA
Phone
Website
Email Address
Overview
VentiRx Pharmaceuticals, Inc. is a biopharmaceutical company committed to the development of novel medicines for the treatment of cancer, infectious, respiratory, and autoimmune diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Hershberg
Chief Medical Officer
James Bryan
Chief Operating Officer
Kathleen Fanning
VP - Finance
Tom Swallow
VP - R & D
Gregory Dietsch
VP - Regulatory Affairs
Tressa Randall
Browse more venture capital transactions:
Prev: 9/23/2014: Eureka Therapeutics venture capital transaction
Next: 9/23/2014: Fuel venture capital transaction
Share this article
Where The Data Comes From
We report on funding rounds that are announced publicly. VC investment data records reported here come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs